Press Releases

Year

May 2010

LifeVantage Announces Unaudited Third Quarter Fiscal 2010 Financial and Operating Results

LifeVantage Announces Unaudited Third Quarter Fiscal 2010 Financial and Operating Results SAN DIEGO , May 17 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of science-based solutions to oxidative stress, announced today unaudited third quarter fiscal 2010

PDF Version

Mar 2010

LifeVantage to Present at ROTH 22nd Annual OC Growth Stock Conference

LifeVantage to Present at ROTH 22nd Annual OC Growth Stock Conference SAN DIEGO , March 12 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of science-based solutions to oxidative stress, announced today that David W.

PDF Version

Feb 2010

LifeVantage Announces Unaudited Second Quarter Fiscal 2010 Financial and Operating Results

LifeVantage Announces Unaudited Second Quarter Fiscal 2010 Financial and Operating Results SAN DIEGO , Feb. 16 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of science-based solutions to oxidative stress, announced today unaudited second quarter fiscal 2010

PDF Version

Jan 2010

LifeVantage Announces Expansion of Board of Directors

LifeVantage Announces Expansion of Board of Directors SAN DIEGO, Jan. 26 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of science-based solutions to oxidative stress, announced today that C. Mike Lu, an independent investor, Kay Stout Manovich, founder of

PDF Version

Jan 2010

LifeVantage Granted Import Approval for Protandim(R) in Mexico

LifeVantage Granted Import Approval for Protandim(R) in Mexico SAN DIEGO, Jan. 6 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of science-based solutions to oxidative stress, announced today that the Company has received formal approval from the Mexican

PDF Version

Jan 2010

LifeVantage Announces Two Human Clinical Trials Investigating the Effects of Protandim(R) on Diseases Affecting the Liver and Lungs

LifeVantage Announces Two Human Clinical Trials Investigating the Effects of Protandim(R) on Diseases Affecting the Liver and Lungs SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of Protandim® and TrueScience Anti-Aging Cream,

PDF Version

Dec 2009

LifeVantage Announces Settlement of Zrii Litigation

LifeVantage Announces Settlement of Zrii Litigation SAN DIEGO, Dec. 18 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of Protandim® and TrueScience Anti-Aging Cream, science-based solutions to oxidative stress, announced today that the Company has

PDF Version

Nov 2009

LifeVantage Announces Unaudited First Quarter Fiscal 2010 Financial and Operating Results

Conference call scheduled for November 18, 2009 at 1:30pm (Pacific); simultaneous webcast at www.lifevantage.com

PDF Version

Nov 2009

American Heart Association Journal, Circulation, Publishes New Peer-Reviewed Study Involving Protandim(R)

American Heart Association Journal, Circulation, Publishes New Peer-Reviewed Study Involving Protandim(R) SAN DIEGO, Nov. 3 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), announced that in a peer-reviewed manuscript published in the prestigious American Heart

PDF Version

Oct 2009

LifeVantage Announces Preliminary Unaudited First Quarter Revenue Company Anticipates Second Consecutive Quarter of Double Digit Percentage Increases in Net Revenue

LifeVantage Announces Preliminary Unaudited First Quarter Revenue Company Anticipates Second Consecutive Quarter of Double Digit Percentage Increases in Net Revenue LifeVantage Announces Preliminary Unaudited First Quarter Revenue Company Anticipates Second Consecutive Quarter of Double Digit

PDF Version

Pagination

First page
Previous page
…
Page 32
Page 33
Page 34
Page 35
Current page 36
Page 37
Page 38
Page 39
Page 40
…
Next page
Last page